Viewing Study NCT01021332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-02-11 @ 3:37 AM
Study NCT ID: NCT01021332
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2009-11-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lower Urinary Tract Symptoms View
None Benign Prostatic Hyperplasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vesomni View
None Solifenacin succinate View
None EC905 View
None Tamsulosin hydrochloride OCAS View
None Treatment View
None Lower Urinary Tract Symptoms View
None Benign Prostatic Hyperplasia View